Treatment of High-Risk Early Stage Lung Cancer

Editors: Bogart, Jeffrey, Detterbeck, Frank (Eds.)

  • Detailed guide to the evaluation and management of high-risk patients with early stage NSCLC
  • Covers the full range of applicable surgical and radiotherapy treatment options plus other approaches
  • Highly relevant for radiation and medical oncologists, thoracic surgeons, interventional radiologists and pulmonologists
see more benefits

Buy this book

eBook  
  • ISBN 978-3-319-08539-5
  • Digitally watermarked, DRM-free
  • Included format:
  • ebooks can be used on all reading devices
Hardcover ca. $109.00
price for USA
  • Due: June 13, 2018
  • ISBN 978-3-319-08538-8
  • Free shipping for individuals worldwide
About this book

Following very significant advances, it is now widely recognized that definitive treatment should be considered in patients with stage I non-small cell lung cancer (NSCLC) who have pulmonary dysfunction and/or other co-morbidities. This book is a detailed guide to the evaluation and management of these high-risk patients. It first addresses issues such as pathologic considerations, assessment of co-morbidity and the imaging and staging of NSCLC. Surgical and radiotherapy treatment options, including sublobar resection, minimally invasive surgery, brachytherapy, stereotactic body radiotherapy and proton and charged particle therapy, are then discussed in detail. The role of radiofrequency ablation, salvage local therapy and systemic chemotherapy is also considered. Treatment of High-Risk Early Stage Lung Cancer will be of great interest to radiation and medical oncologists, thoracic surgeons, interventional radiologists and pulmonologists.

About the authors

Jeffrey A. Bogart, M.D., is the current chair of the Department of Radiation Oncology at Upstate Medical University. Bogart, professor of radiation oncology, joined the SUNY Upstate faculty in 1993. He is currently chair or co-chair of eight Cancer and Leukemia Group B (CALGB)-funded multicenter clinical trials and one National Institutes of Health (NIH) study. He serves on several oversight and advisory committees for the NIH. Bogart, a resident of Jamesville, is an active leader in the CALGB for which he currently serves on its Executive Committee, Board of Directors, and as chair of its Radiation Oncology committee. He is also active in a range of other national organizations in therapeutic radiology and oncology. He is a member of the editorial board of The Journal of Clinical Oncology.


Frank Detterbeck, MD, FACS, FCCP is a Professor of Surgery and Chief of Thoracic Surgery at Yale University and Associate Director of the Yale Cancer Center. He earned a BS in Cell Biology at the University of Michigan, and an MD degree from Northwestern University. After completing general surgery training at the Virginia Mason Clinic in Seattle, he pursued a cardiothoracic fellowship and a fellowship in thoracic transplantation at the University of North Carolina at Chapel Hill. The major focus of his career has been on thoracic oncology. In particular, he has promoted evidence-based care and multidisciplinary teamwork. 

Buy this book

eBook  
  • ISBN 978-3-319-08539-5
  • Digitally watermarked, DRM-free
  • Included format:
  • ebooks can be used on all reading devices
Hardcover ca. $109.00
price for USA
  • Due: June 13, 2018
  • ISBN 978-3-319-08538-8
  • Free shipping for individuals worldwide

Recommended for you

Loading...

Bibliographic Information

Bibliographic Information
Book Title
Treatment of High-Risk Early Stage Lung Cancer
Editors
  • Jeffrey Bogart
  • Frank Detterbeck
Copyright
2018
Publisher
Springer International Publishing
Copyright Holder
Springer International Publishing
eBook ISBN
978-3-319-08539-5
Hardcover ISBN
978-3-319-08538-8
Edition Number
1
Number of Illustrations and Tables
50 b/w illustrations, 50 illustrations in colour
Topics